Based on a unified board of 300 KR·US·JP stocks · updated July 21, 2026 at 02:00 PM KST
TAKEDA PHARMACEUTICAL CO LTD is 1.3× Samsung Biologics
As of July 21, 2026 at 02:00 PM KST, TAKEDA PHARMACEUTICAL CO LTD (4502.T) has a market cap of $54B — #134 worldwide — while Samsung Biologics (207940.KS) stands at $43B, ranking #144. The gap is $11B; Samsung Biologics is 79.4% the size of TAKEDA PHARMACEUTICAL CO LTD.
TAKEDA PHARMACEUTICAL CO LTD ranks #29 among Japan stocks (Healthcare), and Samsung Biologics ranks #7 among Korea stocks (Healthcare).
If Samsung Biologics reached TAKEDA PHARMACEUTICAL CO LTD's market cap, its share price would need to go from $934.56 to $1176.67 (about +26%).